SCHEMBL3258940

SCHEMBL3258940

CCc1cnn(C2CC(n3cnc4c(NC(CC)CC)nc(NC(CO)Cc5ccccc5)nc43)C(O)C2O)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.81
ADORA3 P0DMS8 3/20 0.81
ADORA1 P30542 2/20 0.49
CDK1 P06493 5/20 0.46
CDK5 Q00535 5/20 0.46
CDK2 P24941 5/20 0.45
CCNA2 P20248 3/20 0.45
CCNA1 P78396 3/20 0.45
CACNA1B Q00975 2/20 0.45
CDK7 P50613 3/20 0.44
CDK9 P50750 3/20 0.44
CCNE1 P24864 2/20 0.44
CSNK1D P48730 2/20 0.44
CLK2 P49760 2/20 0.44
CSNK1G2 P78368 2/20 0.44
DYRK1A Q13627 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
CSNK1G1 Q9HCP0 2/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL591113 1.00 ADORA2A (0.81) ADORA2AADORA3ADORA1CDK1CDK5
SCHEMBL591555 0.98 ADORA2A (0.84) ADORA2AADORA3ADORA1CDK1CDK5
SCHEMBL589515 0.91 ADORA2A (0.73) ADORA2AADORA3ADORA1
SCHEMBL588981 0.91 ADORA2A (0.78) ADORA2AADORA3ADORA1CDK1CDK5
SCHEMBL590747 0.90 ADORA2A (1.00) ADORA2AADORA3ADORA1CDK1CDK5
SCHEMBL589213 0.90 ADORA2A (0.74) ADORA2AADORA3ADORA1
SCHEMBL590153 0.88 ADORA2A (0.72) ADORA2AADORA3ADORA1CDK1CDK2
SCHEMBL592302 0.88 ADORA2A (0.69) ADORA2AADORA3ADORA1CDK1CDK5
SCHEMBL592303 0.88 ADORA2A (0.69) ADORA2AADORA3ADORA1CDK1CDK5
SCHEMBL589834 0.86 ADORA2A (0.77) ADORA2AADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2012759-B1 PURINE DERIVATIVES AS A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2010-03-10 EP disclosed